- Home
- SEER vs BTMD Comparison
SEER vs BTMD Comparison
Compare SEER & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- BTMD
- Stock Information
- Founded
- SEER 2017
- BTMD 2012
- Country
- SEER United States
- BTMD United States
- Employees
- SEER N/A
- BTMD N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- SEER Health Care
- BTMD Health Care
- Exchange
- SEER Nasdaq
- BTMD Nasdaq
- Market Cap
- SEER 113.8M
- BTMD 127.8M
- IPO Year
- SEER 2020
- BTMD N/A
- Fundamental
- Price
- SEER $2.04
- BTMD $3.45
- Analyst Decision
- SEER
- BTMD Buy
- Analyst Count
- SEER 0
- BTMD 2
- Target Price
- SEER N/A
- BTMD $6.00
- AVG Volume (30 Days)
- SEER 134.9K
- BTMD 161.7K
- Earning Date
- SEER 11-05-2025
- BTMD 11-11-2025
- Dividend Yield
- SEER N/A
- BTMD N/A
- EPS Growth
- SEER N/A
- BTMD 642.53
- EPS
- SEER N/A
- BTMD 0.88
- Revenue
- SEER $16,288,000.00
- BTMD $199,073,000.00
- Revenue This Year
- SEER $27.77
- BTMD N/A
- Revenue Next Year
- SEER $20.28
- BTMD $4.85
- P/E Ratio
- SEER N/A
- BTMD $3.92
- Revenue Growth
- SEER 10.52
- BTMD 6.32
- 52 Week Low
- SEER $1.62
- BTMD $2.76
- 52 Week High
- SEER $2.63
- BTMD $6.98
- Technical
- Relative Strength Index (RSI)
- SEER 46.20
- BTMD 51.79
- Support Level
- SEER $1.97
- BTMD $3.27
- Resistance Level
- SEER $2.10
- BTMD $3.54
- Average True Range (ATR)
- SEER 0.05
- BTMD 0.16
- MACD
- SEER 0.00
- BTMD 0.03
- Stochastic Oscillator
- SEER 43.75
- BTMD 58.54
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.